Fibroblasts as immune regulators in infection, inflammation and cancerSarah Davidson, Christopher D. Buckley, Mark Coles et al.|Nature reviews. Immunology|2021Cited by 597
IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapiesMatthias Friedrich, Dharshan Sathananthan, Tom Thomas et al.|Nature Medicine|2021Cited by 289
Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathwaysAndrew Filer, Christopher D. Buckley|Arthritis & Rheumatism|2009Cited by 167
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel diseaseTom Thomas, Christopher D. Buckley, Matthias Friedrich et al.|Nature Immunology|2024Cited by 83
A Differential Role for CD248 (Endosialin) in PDGF-Mediated Skeletal Muscle AngiogenesisAmy J. Naylor, Christopher D. Buckley|PLoS ONE|2014Cited by 43